HCA Latest Quarter's Earnings
| Announce Date | 04/26/2024 |
| EPS Normalized Actual | $5.36 (Beat by $0.35) |
| EPS GAAP Actual | $5.36 (Beat by $0.35) |
| Revenue Actual | $14.945B |
| Revenue Surprise | Beat by $14945M |
Upcoming Quarter's Earnings
| Announce Date | 06/30/2024 (Pre-Market) |
| EPS Normalized Estimate | $1.34259 |
| EPS GAAP Estimate | $1.34259 |
| Revenue Estimate | $28.37275B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 29.42 | 10.97 | 28.79635 | 30.15289 | 4 |
| Dec 2026 | 25.42049 | 12.7 | 23.05 | 26.88 | 10 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | 4.2578 | 4.2578 | 14.945B | 6.48% | 14945M |
| FQ4 2021 (Dec 2021) | 5.93826 | 5.93826 | 15.064B | 5.12% | 15064M |
| FQ3 2021 (Sep 2021) | 7.23758 | 7.23758 | 15.276B | 12.86% | 15276M |
| FQ2 2021 (Jun 2021) | 4.4916 | 4.4916 | 14.435B | 23.33% | 14435M |
| FQ1 2021 (Mar 2021) | 4.26412 | 4.26412 | 13.977B | 7.98% | 13977M |
| FQ4 2020 (Dec 2020) | 4.20121 | 4.20121 | 14.293B | 5.39% | 14293M |
| FQ3 2020 (Sep 2020) | 1.97417 | 1.97417 | 13.311B | 4.64% | 13311M |
| FQ2 2020 (Jun 2020) | 3.19268 | 3.19268 | 11.068B | -13.86% | 11068M |
Quarterly Estimates Summary
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
28.37275B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 5.91422 | -- | 5.82282 | 6.04434 | 3 |
| FQ3 2026 (Jul 2026) | 6.01838 | -- | 5.92537 | 6.15079 | 5 |
| FQ2 2026 (Jun 2026) | 6.12172 | -- | 5.98359 | 6.26303 | 9 |
| FQ1 2026 (Mar 2026) | 5.8933 | -- | 5.76032 | 6.02933 | 9 |
| FQ4 2025 (Oct 2025) | 5.25776 | -- | 5.1765 | 5.37344 | 4 |
| FQ3 2025 (Jul 2025) | 5.57114 | -- | 5.48504 | 5.69371 | 6 |
| FQ2 2025 (Jun 2025) | 5.58992 | -- | 5.46379 | 5.71895 | 6 |
| FQ1 2025 (Mar 2025) | 5.61501 | -- | 5.48831 | 5.74462 | 6 |
| FQ4 2024 (Oct 2024) | 4.55377 | -- | 4.33887 | 4.66634 | 8 |
| FQ3 2024 (Jul 2024) | 4.89425 | -- | 4.71483 | 5.0338 | 12 |
| FQ2 2024 (Jun 2024) | 1.34259 | -- | 1.2926 | 1.42025 | 7 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 19.2B | -- | 18.97B | 19.52B | 4 |
| FQ3 2026 (Jul 2026) | 19.14B | -- | 18.92B | 19.47B | 6 |
| FQ2 2026 (Jun 2026) | 19.01B | -- | 18.68B | 19.35B | 6 |
| FQ1 2026 (Mar 2026) | 18.54B | -- | 18.22B | 18.87B | 12 |
| FQ4 2025 (Oct 2025) | 18.11B | -- | 17.89B | 18.42B | 3 |
| FQ3 2025 (Jul 2025) | 17.95B | -- | 17.74B | 18.26B | 5 |
| FQ2 2025 (Jun 2025) | 17.91B | -- | 17.6B | 18.23B | 9 |
| FQ1 2025 (Mar 2025) | 17.67B | -- | 17.37B | 17.99B | 8 |
| FQ4 2024 (Oct 2024) | 17.19B | -- | 17.06B | 17.53B | 8 |
| FQ3 2024 (Jul 2024) | 16.98B | -- | 16.76B | 17.25B | 13 |
| FQ2 2024 (Jun 2024) | 28.37B | -- | 27.98B | 28.88B | 8 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | 4.2578 | 4.2578 | 100% | |
| FQ4 2021 (Dec 2021) | 5.93826 | 5.93826 | 100% | |
| FQ3 2021 (Sep 2021) | 7.23758 | 7.23758 | 100% | |
| FQ2 2021 (Jun 2021) | 4.4916 | 4.4916 | 100% | |
| FQ1 2021 (Mar 2021) | 4.26412 | 4.26412 | 100% | |
| FQ4 2020 (Dec 2020) | 4.20121 | 4.20121 | 100% | |
| FQ3 2020 (Sep 2020) | 1.97417 | 1.97417 | 100% | |
| FQ2 2020 (Jun 2020) | 3.19268 | 3.19268 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | $0B | $14.95B | $14945M | 100% |
| FQ4 2021 (Dec 2021) | $0B | $15.06B | $15064M | 100% |
| FQ3 2021 (Sep 2021) | $0B | $15.28B | $15276M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $14.44B | $14435M | 100% |
| FQ1 2021 (Mar 2021) | $0B | $13.98B | $13977M | 100% |
| FQ4 2020 (Dec 2020) | $0B | $14.29B | $14293M | 100% |
| FQ3 2020 (Sep 2020) | $0B | $13.31B | $13311M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $11.07B | $11068M | 100% |
HCA Ratings Summary
HCA Quant Ranking
